Dr. Hort is a Professor of neurology at Department of Neurology, Charles University, Second Medical Faculty and Motol University Hospital, Prague, Czech Republic and PI of the Czech Brain Ageing Study (CBAS), which is a unique longitudinal prospective study which has been established in 2011 to study the early functional, metabolic and structural biomarkers of Alzheimer ́s Disease and other dementias. (Refer to: www.cbas.cz). Dr. Hort is a director of Cognitive center and coordinator of the Expert center for ERN-RND FTD (European Reference Network for Rare Neurological Diseases for Frontotemporal Dementia) at Motol University Hospital. Dr. Hort has been elected chairman of Section on cognitive neurology of the Czech Neurological Society (2005-2018, 2023-ongoing). Dr. Hort served also as a co-chair of the European Academy of Neurology (EAN) Scientist Panel Dementia and Cognitive Neurology (2015-2019). Dr. Hort authorized European guidelines on Alzheimer disease and participated in EAN guidelines on non-Alzheimer dementias and combination therapy for Alzheimer disease. Dr. Hort has been honored to become Courtesy Professor at University of South Florida, School of Aging Studies since 2019 and member of Expert Advisory Panel of Alzheimer Europe since 2023. In 2023 and 2024 honored by Forbes magazine to be among best 50 physicians in the Czech Republic.
He has served as a reviewer for several peer reviewed journals and international grant agencies. In 2011 he founded Czech Alzheimer fund, which sponsored many research projects and scholarships for young scientists.
Recently dr. Hort has been involved in numerous initiatives to bring novel technologies of artificial intelligence (AI), machine learning, virtual reality and blockchain to both AD research and clinical practice. Dr. Hort is co-founder of telemedicine/blockchain project Terrapino/Alzheimerchain and NFT Non-fungible Brain project.
Dr. Hort has participated in numerous drug development projects as a consultant, SAB member and principal investigator and expert for EMA CHMP oral explanation meeting as well.